دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 30,000,000 تومان- قیمت ویژه : 6,250,000تومان
دسترسی یکماهه به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 31 ﺭﻭﺯ
قیمت : 3,000,000 تومان- قیمت ویژه : 1,250,000تومان
Gaps in Guidelines on Long-Term Management Strategies for Post-Stroke Dysphagia
doi : 10.1111/ene.70307
Thrombolysis After Thrombectomy? Revisiting Intra-Arterial Therapy in the EVT Era
doi : 10.1111/ene.70315
Frequency and Relevance of MYD88L256P Mutation in Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Multifocal Motor Neuropathy
doi : 10.1111/ene.70310
Unreactive EEG Background Is Associated With Unfavorable Outcome in Patients With Disorders of Consciousness of Various Etiologies: An Adult Cohort Study
doi : 10.1111/ene.70312
Systematic Review and Meta-Analysis of Secondary Treatment Failure and Immunogenicity With Botulinum Neurotoxin A in Multiple Indications
doi : 10.1111/ene.70289
Efgartigimod as Add-On Treatment in Refractory Guillain–Barré Syndrome: A Case Report
doi : 10.1111/ene.70308
Beyond the Surface: Investigating the Potential Mechanisms of Non-Motor Symptoms in Myasthenia Gravis
doi : 10.1111/ene.70309
Small Fiber Morphology and Function in Inclusion Body Myositis—A Multimodal Assessment Including Confocal Corneal Microscopy
doi : 10.1111/ene.70294
Military Service and Motor Neuron Disease—Evidence From the Swedish Motor Neuron Disease Quality Registry
doi : 10.1111/ene.70311
Nationwide Phenotypic and Genotypic Characterisation of 103 Patients With SH3TC2 Gene-Related Demyelinating Peripheral Neuropathy
doi : 10.1111/ene.70313
Prevalence of SOD1 and C9orf72 Variants Among French ALS Population: The GENIALS Study
doi : 10.1111/ene.70302
Improvement in Patient-Reported Symptoms of Generalised Myasthenia Gravis With Rozanolixizumab in the Randomised Phase 3 MycarinG Study Using the MG Symptoms PRO
doi : 10.1111/ene.70231
Efgartigimod as a Fast-Acting Add-On Therapy in Antibody–Mediated Autoimmune Encephalitis
doi : 10.1111/ene.70280
Clinical and Genetic Reassessment in Patients With Clinically Diagnosed Hereditary Polyneuropathy
doi : 10.1111/ene.70301
Neurodevelopmental Vulnerability in Alzheimer's Disease and Frontotemporal Dementia
doi : 10.1111/ene.70322
Headache After Sealing of Cerebrospinal Fluid Leaks in Patients With Spontaneous Intracranial Hypotension
doi : 10.1111/ene.70237
Imaging and Clinical Prognostic Features in Lobar Versus Deep Intracerebral Hemorrhage in an Unselected Swedish Population
doi : 10.1111/ene.70318
Cost-Effectiveness of Ultra-Early Tranexamic Acid as Add-On to Standard Care After Subarachnoid Hemorrhage (ULTRA Trial)
doi : 10.1111/ene.70208
Kappa Free Light Chain Index and Oligoclonal Bands in Varicella Zoster Virus Infection and Neuroborreliosis: A Matter of Timing?
doi : 10.1111/ene.70323
Diagnostic Value of the “Insular Knife-Cut” Sign in Patients With Suspected Herpes Simplex Virus Encephalitis
doi : 10.1111/ene.70152
Severity-Dependent Neuroaxonal Damage Assessed by Serum Neurofilaments in ICANS Patients Undergoing CD19-Targeted CAR T-Cell Therapy
doi : 10.1111/ene.70305
Validation of Monocular Pupillometry in Healthy Controls and Patients With Autonomic Dysfunction: Pupillary Biomarkers for Autonomic Failure
doi : 10.1111/ene.70320
The Clinical and Genetic Landscape of a French Multicenter Cohort of 2563 Epilepsy Patients Referred for Genetic Diagnosis
doi : 10.1111/ene.70324
Clinical Neurophysiological Study for the Diagnosis of Functional Cranial–Cervical Dystonia
doi : 10.1111/ene.70287
The Facioscapulohumeral Muscular Dystrophy Rasch-Built Overall Disability Scale (FSHD-RODS): Longitudinal Assessment of a Disease-Specific Patient Reported
doi : 10.1111/ene.70238
Substantia Nigra Hyperechogenicity Predicts Parkinson's Disease Risk in Patients With Essential Tremor and Undetermined Tremor: Dual-Cohort Longitudinal Evidence With 8-Year Follow-Up and Bayesian Validation
doi : 10.1111/ene.70326
Efficacy and Safety of Twelve Anti-Dyskinetic Drugs in Parkinson's Disease: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
doi : 10.1111/ene.70329
Effects of Pausing and Re-Initiating Fremanezumab After Continuous 24-Month Treatment for Preventing Difficult-To-Treat Migraine: Prospective, Multicenter, Real-World Data From the GRASP Study Group
doi : 10.1111/ene.70327
Stress Hyperglycemia Ratio as a Predictor of Parkinson's Disease: Statistical Caveats Matter
doi : 10.1111/ene.70333
Risk Factors Associated With Bell's Palsy: A Real-World Analysis of 281,600 Patients
doi : 10.1111/ene.70336
Clinical Insight on “Association Between Stress Hyperglycemia Ratio and Parkinson's Disease Across Different Glucose Metabolism Statuses—A Prospective Study From UK Biobank”
doi : 10.1111/ene.70340
Correction to “Association Between CD20+ T Lymphocytes and Neuropsychological Findings in Multiple Sclerosis”
doi : 10.1111/ene.70258
Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache: Final Results From a Phase 4 Randomized Placebo-Controlled Study
doi : 10.1111/ene.70328
7 Tesla MRI in Multiple Sclerosis: Insights From Its Use in Clinical Routine
doi : 10.1111/ene.70330
Minimal Clinically Important Difference for the Jamar Hand Grip Dynamometer in CIDP: A Korea-UK Study
doi : 10.1111/ene.70335
Unlocking Relief: Investigating the Impact of a Fixed Combination of Acetyl-L-Carnitine and Palmitoylethanolamide on Traumatic Acute Low Back Pain
doi : 10.1111/ene.70334
Psychological Variables Mediate Symptoms in Persistent Postural-Perceptual Dizziness (PPPD): A Cross-Sectional Self-Report Study
doi : 10.1111/ene.70339
Uncovering Hidden Profiles: From Pain-Centric to Multi-Symptom Small Fiber Neuropathy
doi : 10.1111/ene.70321
Is a Novel Transthyretin Gene Mutation Associated With Cerebral Amyloid Angiopathy?
doi : 10.1111/ene.70217
